Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/30/2003WO2002020090A9 Pharmaceutical compositions
10/30/2003WO2002007700A8 Compositions useful for regulating hair growth containing metal complexes of oxidized carbohydrates
10/30/2003WO2002007685A8 Method of regulating hair growth using metal complexes of oxidized carbohydrates
10/30/2003WO2001097794A8 Inhibitors of matriptase for the treatment of cancer
10/30/2003WO2001085154A8 Method of treating immune pathologies with low dose estrogen
10/30/2003WO2001051054A3 Use of cyclopentenone derivatives for bone and periodontal regeneration
10/30/2003US20030204168 Coated vascular devices
10/30/2003US20030204103 2-Methylene-19-nor-20(S)-1alpha-hydroxy-bis-homo-pregnacalciferol in crystalline form
10/30/2003US20030204093 Useful as a pharmaceutical either alone or in combination with amlodipine in treating angina and hypertension
10/30/2003US20030204090 Administering to a patient an indazoline compound to treat cancer, inflammatory disorder or autoimmune disease
10/30/2003US20030204089 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204082 To an aqueous solution of cefdinir an organic solvent is added in a percentage v/v up to 10%, the solution is cooled to a temperature 0-6 degree C. in acedic pH, to enhance precipitation of cefdinir new crystals
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030203976 Anti-angiogenic compositions and methods of use
10/30/2003US20030203975 Such as complex of amino acid/peptide and 1-(2-hydroxyethylamino)anthracene-9,10-dione
10/30/2003US20030203974 Topical administration of dihydroxytoluene to block viral replication
10/30/2003US20030203973 Administering triethylenetetramine to lower copper value of myocardium; for treatment of diabetes
10/30/2003US20030203972 Enantiomers of N-desmethyl venlafaxine
10/30/2003US20030203971 Therapeutic agent
10/30/2003US20030203970 Bronchodilators; adrenergic agonists; side effect reduction
10/30/2003US20030203969 Pharmaceutically active aromatic guanylhydrazones
10/30/2003US20030203968 Levothyroxine compositions and methods
10/30/2003US20030203967 Levothyroxine compositions having unique Tmax properties
10/30/2003US20030203966 Such as N-(3,5-dimethyl-4-((nitromethyl)sulphonyl) phenyl)benzenesulphonamide for treatment/prevention of peripheral and autonomous neurolgical diabetic complications, renal and ocular disorders (cataracts, retinopathy)
10/30/2003US20030203965 Benzyl (S,S)-2-(2-acetylsulphanylmethyl-3-benzo(1,3)dioxol-5-ylpropionyl -amino)propionate; differential scanning calorimetry; for treatment of hypertension/cardiovascular system disorders
10/30/2003US20030203964 Process for producing medicaments which comprise HMG CoA reductase inhibitors
10/30/2003US20030203962 Purified plant proanthocyanidin extract, capable of inhibiting agglutination of P-type Escherichia coli and not capable of inhibiting agglutination of type 1 Escherichia coli; proanthocyanidin having 4-12 epicatechin flavanoid units
10/30/2003US20030203961 A taxane joined by a hydrolyzable bond to one or more oligomers that containing a polyethylene glycol group and a tert-amide group
10/30/2003US20030203960 Drugs for prophylaxis or mitigation of taxane-induced neurotoxicity
10/30/2003US20030203959 Novel modulators of potassium channels
10/30/2003US20030203958 Therapeutic inhibitor of vascular smooth muscle cells
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203956 Method of using a cyclooxygenase-2 inhibitor and one or more ornithine decarboxylase inhibitors as a combination therapy in the treatment of neoplasia
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203954 Substituted 3, 5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
10/30/2003US20030203953 Repinotan kit
10/30/2003US20030203952 Novel processes for making- and a new crystalline form of- leflunomide
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203948 Compounds having anti-hepatitics c virus effect
10/30/2003US20030203947 Activator of PPAR delta
10/30/2003US20030203946 Glucagon antagonists/inverse agonists
10/30/2003US20030203945 Coupling a heterocyclic compound containing amine group with a 4-nitrophenyl-1-oxycarbonyl or derivative useful for the treatment of neurological conditions
10/30/2003US20030203944 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
10/30/2003US20030203943 A chemical complex of niacinamide and H2 histamine receptor antagonist which is selected from ranitidine, cimetidine, famotidine, nizatidine and derivatives; a medicament or a dietary- supplement for immunomodulation in a mammal
10/30/2003US20030203942 Treatment of post-angioplasty restenosis and atherosclerosis with Ras antagonists
10/30/2003US20030203940 Oxadiazole derivatives having anticancer effects
10/30/2003US20030203939 Administration of an isoxazole derivative as Farnesoid X Receptor(FXR) ligand for the treatment of liver disease (cholestasis)
10/30/2003US20030203938 Epothilone derivatives and their synthesis and use
10/30/2003US20030203937 Use in treating medical disorders such as depression, obsessive compulsive disorder, and panic
10/30/2003US20030203934 3-(substituted phenyl)-2-(substituted)tropane analogs which bind to cocaine receptors, dopamine transporter, serotonin transporter
10/30/2003US20030203933 Novel curcumin analogues and uses thereof
10/30/2003US20030203932 Amonafide salts
10/30/2003US20030203931 Polymorph of a pharmaceutical
10/30/2003US20030203930 Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/30/2003US20030203929 Microtubule stabilizing compounds
10/30/2003US20030203927 Thrombin receptor antagonists
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203925 Use in the treatment of respiratory tract diseases
10/30/2003US20030203924 Combination for treating susceptible tumor comprising (S)-2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f) quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid and folic acid
10/30/2003US20030203923 Method of inhibiting neurotrophin-receptor binding
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203921 GABA analogs and an antiviral agent to treat shingles
10/30/2003US20030203920 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203918 Pharmaceutical composition comprising an anticholinergic and a heterocyclic compound
10/30/2003US20030203917 Compounds and methods for the treatment of neoplastic disease
10/30/2003US20030203916 1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203914 Implicated as playing a key role in processes involving cellular invasion and tissue remodelling including wound repair, bone remodelling, angiogenesis, tumour invasiveness and spread of metastases
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003US20030203912 Serotonergic 5HT2 agonists for treating glaucoma
10/30/2003US20030203910 A phenoxy-alkyl-quinoxalinone derivatives for inhibiting drug transport proteins that efflux therapeutic agents from cells; synergistic
10/30/2003US20030203909 A N-phenyl-benzo(b)thiophene-carboxamide derivatives, as enzyme inhibitor of tyrosine kinase; antiproliferation of lymphocyte, treating autoimmune disease, rheumatic disease, as immunosuppressant, antiinflammatory agents
10/30/2003US20030203908 A triazine enzyme inhibitors for treating malaria, parasite disease, Chagas' disease, sleep disorder or Toxoplasma goudii; chemical intermediate synthesis
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203904 Antitumor agents for treating cancer
10/30/2003US20030203903 Administering a rifamycin microbiocides for treating infections caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae or Helicobacter pylori
10/30/2003US20030203899 Drugs for incontinence
10/30/2003US20030203898 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/30/2003US20030203897 2,4-Disubstituted thiazolyl derivatives
10/30/2003US20030203896 Novel guanidino derivatives as inhibitors of cell adhesion
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203892 A synergistic therapeutic treatment for hypercholesterolemic condition
10/30/2003US20030203890 Administering a neurotrophic compound 2-pyrrolidinecarboxylate derivatives after prostate surgery as well as erectile dysfunction
10/30/2003US20030203889 Phenylsulphonyl derivatives as 5-HT receptor ligands
10/30/2003US20030203887 Methods for in vivo reduction of free radical levels and compostions useful therefor
10/30/2003US20030203886 Process for the production of clavulanic acid salts
10/30/2003US20030203885 Cholesterol and hedgehog signaling
10/30/2003US20030203884 Comprises pregn-4-ene-7,21-dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-, gamma-lactone, methyl ester for treatment of hypertension, cardiovascular/kidney disorders, liver diseases, and other conditions associated with salt intake
10/30/2003US20030203883 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
10/30/2003US20030203882 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer
10/30/2003US20030203881 Comprises administration of tetracycline compound for treatment of Alzheimer's/Parkinson's diseases
10/30/2003US20030203878 Comprises non-hydrated hydrogel, superdisintegrant, and tannic acid; for treatment of metastatic bone diseases (hypercalcemia)
10/30/2003US20030203876 Comprises epothilone in form of infusion concentrate or lyophilised composition
10/30/2003US20030203875 Comprises artesunic acid complexed with cyclodextrins, which shields peroxide portion of artemisinin backbone from hydrolytic decomposition; for treatment of malaria
10/30/2003US20030203874 Revitalization formulation
10/30/2003US20030203873 Method for treatment of neuropsychiatric disorders
10/30/2003US20030203872 Such as 1-(4-thio-beta-D-arabinofuranosyl)cytosine for treatment of cancer; gene expression inhibition
1 ... 5292 5293 5294 5295 5296 5297 5298 5299 5300 5301 5302 5303 5304 5305 5306 5307 5308 5309 5310 5311 5312 ... 7860